Trials / Conditions / Lung Cancer Squamous Cell
Lung Cancer Squamous Cell
7 registered clinical trials studyying Lung Cancer Squamous Cell — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | To Evaluate the Efficacy and Safety of Inhaled Corticosteroids Combined With Bronchodilators and Programmed De NCT06772454 | Guangzhou Institute of Respiratory Disease | — |
| Terminated | Bispecific PSMAxCD3 Antibody CC-1 in Patients With Squamous Cell Carcinoma of the Lung NCT04496674 | German Cancer Research Center | Phase 1 / Phase 2 |
| Unknown | Glypican-1 Expression in Epithelioid Mesothelioma, Adenocarcinoma and SCC of the Lung NCT05228795 | Sohag University | — |
| Terminated | Electrocautery Ablation for the Prevention of Lung Cancer NCT03870152 | University College, London | Phase 2 / Phase 3 |
| Unknown | Study of CT and MR in the Lung Cancer NCT04034667 | Henan Cancer Hospital | — |
| Unknown | A Study of SHR-1210 in Combination With Carboplatin + Paclitaxel in Subjects With Squamous NSCLC NCT03668496 | Jiangsu HengRui Medicine Co., Ltd. | Phase 3 |
| Suspended | Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib NCT03065062 | Dana-Farber Cancer Institute | Phase 1 |